Literature DB >> 116292

Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.

J A Stauning, L Kirk, A Jøorgensen.   

Abstract

The serum concentrations of cis(Z)-flupentixol after injection of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo (Depixol injection, Fluanxol Depot) have been investigated in a crossover study with eight schizophrenic patients. No statistically significant difference was found between the two preparations when the data from individual days or areas under the serum concentration curves were considered. For the individual patients a difference was found between the two treatments in six cases; one preparation gave the higher serum concentration in four cases and the other preparation in two cases. Thus, the difference found within individual patients reflects the intraindividual variation rather than a difference between preparations. The maximum serum concentration was seen at 4 or 7 days after injection. The maximum/minimum fluctuation ratio indicates that dosage intervals longer than 2 weeks seem reasonable for most of the patients. The similarity in the serum concentrations, no matter which concentration of flupentixol decanoate solution was given, indicates that a dispersal and possibly a metabolic breakdown of the oil depot takes place in the muscle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116292     DOI: 10.1007/bf00491981

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Flupenthixol decanoate--in treatment of out-patients.

Authors:  C G Gottfries; L Green
Journal:  Acta Psychiatr Scand Suppl       Date:  1974

2.  [One years experience with high doses of Flupenthixol-decanoate 10 per cent (Lu 1705)].

Authors:  K Bjerke; A Faurbye; L Kirk
Journal:  Nord Psykiatr Tidsskr       Date:  1972

3.  [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].

Authors:  H Gross; E Kaltenbäck
Journal:  Wien Klin Wochenschr       Date:  1972-02-04       Impact factor: 1.704

4.  Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds.

Authors:  A Jorgensen; C G Gottfries
Journal:  Psychopharmacologia       Date:  1972

5.  [Clinical trial of flupenthixol decanoate as a depot neuroleptic].

Authors:  C G Gottfries
Journal:  Nord Psykiatr Tidsskr       Date:  1971

6.  A sensitive and specific radioimmunoassay for cis (Z)-flupenthixol in human serum.

Authors:  A Jørgensen
Journal:  Life Sci       Date:  1978-10-16       Impact factor: 5.037

7.  The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol.

Authors:  M W Carney; B F Sheffield
Journal:  Curr Med Res Opin       Date:  1973       Impact factor: 2.580

8.  A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.

Authors:  C Astrup; A Grimgård; K Hebnes; A Kruse-Jensen; M Lid
Journal:  Acta Psychiatr Scand       Date:  1974       Impact factor: 6.392

  8 in total
  8 in total

Review 1.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.

Authors:  T Aaes-Jørgensen; L Kirk; E Petersen; P Danneskiold-Samsøe; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.

Authors:  J K Saikia; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.

Authors:  A Jørgensen
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

6.  Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.

Authors:  A Jørgensen; J Andersen; N Bjørndal; S J Dencker; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Low doses of cis-flupentixol attenuate motor performance.

Authors:  G M Heyman; M M Monaghan; D E Clody
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.

Authors:  Jataveda Mahapatra; Seema N Quraishi; Anthony David; Stephanie Sampson; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.